Terbinafine Hydrochloride
Product Images NDC 63629-2807

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Terbinafine Hydrochloride (NDC 63629-2807). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

3a183255-figure-01 (3a183255 Figure 01)

A data table comparing adverse events and discontinuation rates between Lamisil and placebo groups. It lists percentages for symptoms such as headache, gastrointestinal symptoms (diarrhea, dyspepsia, abdominal pain, nausea, flatulence), dermatological symptoms (rash, pruritus, urticaria), liver enzyme abnormalities, taste disturbance, and visual disturbance with sample sizes indicated for each group.*

FDA Label Image

3a183255-figure-02 (3a183255 Figure 02)

Chemical structure of Terbinafine Hydrochloride, depicting the molecular arrangement with rings, double bonds, and functional groups including a hydrochloride component.*

FDA Label Image

3a183255-figure-03 (3a183255 Figure 03)

This text panel lists common side effects associated with a medication. Visible side effects include nausea, stomach (abdominal) pain, rash, headache, vomiting, dizziness, and frequent urination. The information likely pertains to the drug Terbinafine Hydrochloride from Bryant Ranch Prepack, but the image shows only the list of side effects without drug-specific branding.*

FDA Label Image

3a183255-figure-04 (3a183255 Figure 04)

A partial text panel listing side effects and symptoms related to medication use. Visible symptoms include nausea, poor appetite, tiredness, vomiting, abdominal pain in the upper right stomach, skin or eye yellowing (jaundice), dark (tea-colored) urine, and pale or light-colored stools.*

FDA Label Image

Label Image (Lbl636292807)

Terbinafine 250 mg tablets packaging label by Bryant Ranch Prepack. The label indicates the product is a 30-count bottle of tablets. It includes storage instructions to keep at room temperature of 20-25°C (68-77°F) and a safety warning to keep drugs out of reach of children. The label compares this product to Lamisil 250 mg tablets by Cipla Ltd. The product NDC is 63629-2807-1.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.